Mayo Clinic Florida is a comprehensive medical center belonging to the Mayo Clinic in Jacksonville, Florida. It is one of three Mayo campuses along with Phoenix/Scottsdale, Arizona and Rochester, Minnesota.

There are 304 beds in Mayo Clinic Hospital.

During the past decade, Mayo Clinic Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mayo Clinic Hospital" #1 sponsor was "Biogen" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Camurus AB" with 1 trials sponsored, "Cornerstone Pharmaceuticals" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mayo Clinic Hospital" #1 collaborator was "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Vanderbilt University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic Hospital" are "Amyotrophic Lateral Sclerosis" (2 trials), "AL Amyloidosis" (1 trials), "Acute Ischemic Stroke" (1 trials), "Castrate-Resistant Prostate Cancer" (1 trials) and "Cirrhosis" (1 trials). Many other conditions were trialed in "Mayo Clinic Hospital" in a lesser frequency.

Most popular intervention types in "Mayo Clinic Hospital" are "Drug" (16 trials), "Biological" (3 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Atezolizumab" (2 trials), "Argatroban" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "BIIB054" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic Hospital" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Mayo Clinic Hospital". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Mayo Clinic Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic Hospital, 6 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".